The first human cases of infection with avian influenza A(H7N9) virus were reported in March 2013 in China. The number of confirmed cases continues to increase, although almost all the cases are limited to China. In this study, a one-step real-time RT-PCR assay was developed for detecting the novel A(H7N9) virus. This assay was shown to have high specificity, good linearity, and high sensitivity to a broad range of Eurasian H7 viruses. The assay is useful both for diagnostic purposes in cases of suspected human infection with the influenza A(H7N9) virus and in the surveillance of both avian and human influenza viruses. A diagnostic system using this assay was prepared at 74 prefectural and municipal public health institutes and 16 quarantine stations in Japan early into the human H7N9 infection outbreaks, enabling potential diagnoses of H7N9 infection across Japan.
INTRODUCTION
The first human cases of infection with avian influenza A(H7N9) virus were reported by the National Health and Family Planning Commission, China, on March 31, 2013. A total of 135 cases of H7N9 human infection, including 44 deaths, were confirmed by August 13, 2013 , and more than 200 additional human cases of infection with H7N9 were reported in China between October 2013 and February 2014 (1, 2) . The H7N9 viruses are reassortants that acquired the H7 hemagglutinin (HA) and N9 neuraminidase (NA) genes from Eurasian avian influenza viruses and the remaining 6 genes from the recent influenza A(H9N2) virus spreading in China. In addition, human H7N9 viruses have several characteristic amino acid changes in the HA gene and the PB2 RNA polymerase subunit, which probably facilitate binding to human-type receptors and efficient replication in mammals, respectively; these highlight the pandemic potential of the novel viruses (3, 4) . Indeed, imported cases of human H7N9 infections from China have been confirmed in Taiwan and Malaysia (2, 5, 6) .
A laboratory-based diagnostic system for the H7N9 virus using a highly sensitive and specific one-step realtime RT-PCR assay for detecting Eurasian-lineage H7 influenza viruses (H7 rRT-PCR assay), along with conventional RT-PCR methods, was developed by the National Institute of Infectious Diseases in Japan to monitor and diagnose human H7N9 infections. These methods have been shown to perform well as a result of using the human H7N9 isolate received from the Chinese Center for Disease Control and Prevention (CCDC) on April 12, 2013. Screening of individuals with suspected H7N9 infection, defined as fever ＞389 C, acute respiratory symptoms and a history of residence or travel in China within 10 days, continues across Japan at bases in 74 prefectural and municipal public health institutes and 16 quarantine stations using the H7N9 diagnostic kit distributed on April 16, 2013. As of March 14, 2014 , no cases of imported human H7N9 infection have been confirmed in Japan.
MATERIALS AND METHODS
Primer and probe design: The primers and probe for the H7 rRT-PCR assay for specific detection of Eurasian-lineage H7 subtype influenza A viruses were designed based on multiple alignments of Eurasian H7 HA gene sequences from the Global Initiative on Sharing All Influenza Data (GISAID) database. Nucleotide sequences of primers and the minor groove binder (MGB) TaqMan  probe (Life Technologies Japan, Tokyo, Japan) for this assay are shown in Table 1 and were designed for the highly conserved HA2 regions.
Viral RNA extraction for evaluation of the assay: The novel human H7N9 virus, A/Anhui/1/2013 (H7N9) and 7 Eurasian H7 avian influenza A viruses-A/duck/ Fukui In vitro-transcribed RNA: In vitro-transcribed RNAs were used as standards for the H7 rRT-PCR assay. RNA transcripts of the full-length H7 HA and matrix (M) genes were synthesized from RNA extracted from A/Anhui/1/2013 (GISAID accession no. EPI439507) and A/Narita/1/2009 (H1N1pdm09) (EPI179437), respectively, by the following procedure: Uni12 primer , and the absorbance value was used to calculate the copy number. The integrity of transcribed RNAs was assessed with a 2100 BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). Transcript dilutions were performed in nuclease-free water containing 10 ng/mL of carrier RNA (Qiagen). One-step real-time RT-PCR assay: The rRT-PCR assay was performed in a 25-mL PCR reaction that comprised 600 nM of each forward and reverse primer, 100 nM of TaqMan MGB probe, 12.5 mL of the 2× QuantiTect Probe RT-PCR Master Mix, 0.25 mL of the QuantiTect RT Mix with the QuantiTect Probe RT-PCR Kit (Qiagen), 2 U RNase Inhibitor (Applied Biosystems, Foster City, CA, USA), and 5 mL of RNA as the template. The rRT-PCR assays were performed with a LightCycler  480 II (Roche, Basel, Switzerland) under the following conditions: 509 C for 30 min, 959 C for 15 min, and 45 cycles of 15 s at 949 C, and 75 s at 569 C. Amplification data were collected and analyzed using the second derivative maximum method in the LightCycler  480 SW1.5 software. In this study, the copy number of the M gene of the 8 H7 viruses was determined quantitatively using the influenza A (Type A) rRT-PCR assay targeted for the universal M gene of all influenza A viruses (8) using known concentrations of in vitro-transcribed RNA of the M gene of A/Narita/1/ 2009 as the standard.
Validation and evaluation of the one-step real-time RT-PCR assay: The analytical sensitivity of the assay was assessed by testing serial dilutions of quantified in vitro-transcribed RNA in 6 replicates at each concentration. The limit of detection (LOD) was calculated by probit regression analysis (9) with a 95z probability endpoint. For evaluation of the H7 rRT-PCR assay, both the H7 and Type A rRT-PCR assays were performed at the same time using three 10-fold serial dilutions of the 8 Eurasian H7 influenza A viruses in triplicate; the number of positive results obtained by each assay was compared and the average crossing point (Cp) values were defined.
The specificity of the H7 rRT-PCR assay was validated using 23 representative subtypes of influenza A and influenza B viruses and 18 viral respiratory pathogens (Table 2A and B) .
Phylogenetic analysis of HA gene: Phylogenetic analysis was performed using the Molecular Evolutionary Genetics Analysis software (MEGA, version 5.0) (10). Evolutionary history was inferred using the neighborjoining method (11) . Evolutionary distances were computed using Kimura's two-parameter method (12) . The bootstrap values of the HA genes were calculated from 1,000 replicates (13) .
RESULTS
Sensitivity and specificity of the one-step real-time RT-PCR assay: The LOD of the H7 rRT-PCR assay was determined by testing serial dilutions of quantified in vitro-transcribed RNA of the HA gene A/Anhui/1/ 2013 in 6 replicates, resulting in 5.2 copies per reaction. The efficiency of this assay was 99.2z, and the R 2 value, which compare the log of the template concentrations with Cp values, was 1.0 at 5.0-5.0 × 10 7 copies per reaction (Fig. 1) . A precise log-linear relationship between the template concentration and Cp value was observed over a broad dynamic range.
Evaluation of the H7 rRT-PCR assay was performed using three 10-fold serial dilutions of RNAs of the 8 Eurasian H7 viruses. The copy number of the M gene of each virus was quantitated using the Type A rRT-PCR assay ( Table 3 ). All viruses were detectable using the H7 rRT-PCR assay. The 7 viruses, except for A/quail/ Aichi/1/2009, could be identified as H7 HA subtypes using the H7 rRT-PCR assay with templates at a low concentration; the difference in Cp values between the Type A rRT-PCR and the H7 rRT-PCR assay (DCp) was less than 1.4 and the standard deviation (SD) of the triplicate Cp values was less than 0.85. These results indicate that the H7 rRT-PCR assay has high sensitivity for these 7 viruses, similar to the Type A rRT-PCR assay. When the assays were performed using A/quail/ Aichi/1/2009, the DCp of the 10 -5 dilution was high, and the HA gene could not be detected using the H7 rRT-PCR assay at lower concentrations.
The specificity of the assay was validated using representative non-H7 influenza A and influenza B viruses and other viral respiratory pathogens (Table 2A and B). The assay showed no cross-reactivity with any of the other subtypes of influenza A and B viruses or respiratory pathogens (data not shown).
Phylogenetic analysis: The phylogenetic tree of 69 representative H7 HA coding sequences from the GISAID database, including the 8 Eurasian H7 viruses, is shown in Fig. 2 . Among the 8 Eurasian H7 viruses used for evaluation of the H7 rRT-PCR assay, the HA genes of A/duck/Fukui/1/2004 and A/quail/Aichi/1/ 2009 had the shortest and the longest distances from A/Anhui/1/2013, respectively (nucleotide identity 94.7z vs. 84.7z).
DISCUSSION
The HA gene of A/duck/Fukui/1/2004 (H7N7) (EPI447361) shared the highest nucleotide identity (94.7z) with A/Anhui/1/2013 in our influenza virus library (Fig. 2 ), and this virus was therefore used for developing the H7 rRT-PCR assay until the arrival of the H7N9 virus from the CCDC on April 12, 2013. The newly established rRT-PCR assay for detecting the novel H7N9 virus showed good linearity and high sensitivity using in vitro-transcribed RNA of the HA gene of A/Anhui/1/2013 (Fig. 1) . The LOD of the H7 rRT-PCR assay was comparable with that of our previously developed rRT-PCR assay for the universal detection of the M gene of all influenza A viruses (8) . Because the sequences of both primers and the probe were designed for the highly conserved region of the HA gene of Eurasian H7 viruses, the H7 rRT-PCR assay showed high sensitivity to a broad range of Eurasian H7 avian influenza viruses (Table 3) . No cross-reactivity or nonspecific reactions were observed in this assay, which was performed using other subtypes of influenza A and influenza B viruses (Table 2A) or other respiratory viruses (Table 2B) .
A/quail/Aichi/1/2009 had 4 mismatches in the forward primer, 2 in the reverse primer, and 2 in the probe region, however, A/duck/Fukui/1/2004 had no mis- As the endpoint fluorescence intensities of the H7 rRT-PCR assays using these 4 viruses were lower than those of the assays using the other viruses due to 1 mismatch (data not shown), the sensitivity of the H7 rRT-PCR assay remained unchanged (Table 3) . Viral RNA of A/duck/Fukui/1/2004 was distributed to 74 prefectural and municipal public health institutes and 16 quarantine stations in Japan as a positive control for the assay, along with the protocol, primers, probe, and reagents as a diagnostic kit for H7N9 on April 16, 2013. In Japan, these aforementioned facilities are involved in screening for human H7N9 infections. No human H7N9 infection cases have been confirmed to date, despite the many diagnostic procedures performed across Japan.
At present, animal reservoirs and the specific mode of transmission of the virus to humans are still being investigated and the virus may be more widespread among poultry (14) . The risk of H7N9 exposure may be limited to China; however, continuous surveillance activities are still needed to monitor avian, animal, and human viral infections in other areas. The newly developed H7 rRT-PCR assay was shown to be highly sensitive, with the ability to detect both novel H7N9 and other avian Eurasian H7 influenza A viruses. This H7 rRT-PCR assay is useful not only for diagnostic purposes in cases of suspected human H7N9 infection but also for the surveillance of avian and animal influenza infections.
